Despite this, NHE1 continues to be investigated for its importance in tumor cell progression and in particular cell migration/metastasis and blockade of the H+ secreting strategy in cancer cells remains an attractive therapeutic target [14–17]. The gene discussed is SLC9A1; the disease is neoplasm.